🔎 Trials Near Me

Utama › Kanser Pundi Kencing › Georgia › Atlanta

Kajian klinikal Kanser Pundi Kencing di Atlanta, GA

16 kajian untuk Kanser Pundi Kencing sedang mencari peserta di lokasi dalam dan sekitar Atlanta (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Mengambil pesertaFasa 1
  • Emory University, Atlanta
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06465069

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Atlanta VA Medical Center, Decatur · 6 mi jauh
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Mengambil pesertaFasa 2
  • Grady Health System, Atlanta
  • Emory Proton Therapy Center, Atlanta
  • Emory University Hospital Midtown, Atlanta
  • dan 2 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06770582

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Mengambil pesertaFasa 2
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT03866382

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

Mengambil pesertaFasa 1
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital, Atlanta
  • Emory University, Atlanta
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07206225

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

Mengambil pesertaFasa 1
  • The Winship Cancer Institute Emory University, Atlanta
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07217171

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Mengambil pesertaFasa 2
  • Emory University, Atlanta
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06567743

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

Mengambil pesertaFasa 3
  • Urology of Greater Atlanta - Sandy Springs, Atlanta
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT07480356

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Mengambil pesertaFasa 1
  • Emory University Hospital, Atlanta
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT05614739

Measuring Surgical Recovery After Radical Cystectomy

Mengambil pesertaKajian pemerhatian
  • Emory University, Atlanta
Umur 18 ke atas · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT03193970

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Mengambil pesertaFasa 3
  • Grady Health System, Atlanta
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • dan 1 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT07097142

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Mengambil pesertaFasa 1/2
  • Emory University, Atlanta
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT04752722

Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology

Mengambil pesertaFasa 2
  • Grady Health System, Atlanta
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • dan 1 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jul 2026 · NCT05756569

Blue Light Cystoscopy With Cysview® Registry

Mengambil pesertaKajian pemerhatian
  • Emory University School of Medicine, Atlanta
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Dis 2025 · NCT02660645

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, Atlanta
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

A Beta-only IL-2 ImmunoTherapY Study

Mengambil pesertaFasa 1/2
  • Emory - Winship Cancer Institute, Atlanta
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Jul 2025 · NCT05086692

Kajian Kanser Pundi Kencing di bandar lain

Kajian lain di Atlanta

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.